Martyn Jacobs
Stock Analyst at Bell Potter
(0.06)
# 4,739
Out of 5,028 analysts
208
Total ratings
18.9%
Success rate
-15%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: AYA Artrya Limited | Reiterated: Buy | $6.00 | $3.12 | +92.62% | 7 | Oct 4, 2026 | |
| ASX: EBR EBR Systems, Inc. | Reiterated: Buy | $0.70 | $0.26 | +169.23% | 21 | Sep 29, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Hold | $0.77 → $0.75 | $0.75 | - | 9 | Aug 31, 2026 | |
| ASX: ONE Oneview Healthcare PLC | Reiterated: Buy | $0.42 | $0.14 | +200.00% | 11 | Aug 31, 2026 | |
| ASX: AHC Austco Healthcare Limited | Reiterated: Buy | $0.45 | $0.24 | +85.95% | 5 | Aug 30, 2026 | |
| ASX: LDX Lumos Diagnostics Holdings Limited | Reiterated: Buy | $0.25 | $0.11 | +138.10% | 4 | Aug 28, 2026 | |
| ASX: TRJ Trajan Group Holdings Limited | Reiterated: Buy | $0.75 → $0.50 | $0.25 | +104.08% | 16 | Aug 28, 2026 | |
| ASX: BIO Biome Australia Limited | Reiterated: Buy | $0.75 | $0.40 | +87.50% | 20 | Aug 27, 2026 | |
| ASX: IPD ImpediMed Limited | Reiterated: Buy | $0.01 | $0.01 | +66.67% | 16 | Aug 27, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.60 → $3.15 | $2.13 | +47.89% | 9 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.15 | $1.60 | +97.49% | 10 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.00 | $0.43 | +132.56% | 16 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.75 → $27.50 | $18.72 | +46.90% | 7 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.15 | $3.69 | +39.57% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.013 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.017 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.049 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.80 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.90 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.096 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.051 | n/a | 7 | Oct 31, 2022 |
Artrya Limited
Oct 4, 2026
Reiterated: Buy
Price Target: $6.00
Current: $3.12
Upside: +92.62%
EBR Systems, Inc.
Sep 29, 2026
Reiterated: Buy
Price Target: $0.70
Current: $0.26
Upside: +169.23%
Monash IVF Group Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $0.77 → $0.75
Current: $0.75
Upside: -
Oneview Healthcare PLC
Aug 31, 2026
Reiterated: Buy
Price Target: $0.42
Current: $0.14
Upside: +200.00%
Austco Healthcare Limited
Aug 30, 2026
Reiterated: Buy
Price Target: $0.45
Current: $0.24
Upside: +85.95%
Lumos Diagnostics Holdings Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $0.25
Current: $0.11
Upside: +138.10%
Trajan Group Holdings Limited
Aug 28, 2026
Reiterated: Buy
Price Target: $0.75 → $0.50
Current: $0.25
Upside: +104.08%
Biome Australia Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $0.75
Current: $0.40
Upside: +87.50%
ImpediMed Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $0.01
Current: $0.01
Upside: +66.67%
Integral Diagnostics Limited
Aug 26, 2026
Reiterated: Buy
Price Target: $3.60 → $3.15
Current: $2.13
Upside: +47.89%
Aug 25, 2026
Reiterated: Buy
Price Target: $3.15
Current: $1.60
Upside: +97.49%
Aug 24, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.43
Upside: +132.56%
Aug 20, 2026
Reiterated: Buy
Price Target: $28.75 → $27.50
Current: $18.72
Upside: +46.90%
Aug 5, 2026
Reiterated: Buy
Price Target: $5.15
Current: $3.69
Upside: +39.57%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.013
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.017
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.049
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.80
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.90
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.096
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.051
Upside: n/a